글로벌 글랜더스 치료 시장 – 2029년까지의 산업 동향 및 예측

글랜더스 치료 시장 분석 및 규모

글로벌 글랜더스 치료 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 공공 및 민간 건강 보험의 잘 정의된 환불 정책의 증가는 시장 성장을 확대하는 중요한 요인입니다. COVID-19 팬데믹의 갑작스러운 발발은 전 세계적으로 엄격한 봉쇄 규정을 부과하여 글랜더스 치료 시장의 수입 및 수출 활동이 중단되었습니다. 질병 유병률은 매우 드뭅니다. 부적절한 사육, 열악한 사료 공급 조건 및 동물 운송은 글랜더스를 전파할 수 있는 몇 가지 요인입니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 글랜더스 치료 시장의 성장률을 분석합니다. 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함됩니다.

시장 정의

비강선은 Burkholderia mallei라는 박테리아에 의해 발생하는 감염성 질환입니다. 증상은 근육 경직, 흉통, 두통, 비강 분비물입니다. 비강선을 담당하는 박테리아는 감염된 동물의 조직이나 체액과의 접촉을 통해 인간에게 전염됩니다. 이 질병 유병률은 증가하고 있으며 중요한 진단 절차와 치료가 시장 성장을 촉진할 것입니다.

보고 범위 및 시장 세분화

Global Glanders Treatment Market Dynamics

Drivers

• Availability of Advanced Treatment Procedures

With each passing decade, varied treatment methods are being available that would help the patients' faster recovery. Development of varied advanced devices are providing high output, performing several tests in a very short duration of time, and reducing weight time significantly. Thus, it acts as a major driver in the market growth.

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the global glanders treatment market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.

Opportunities

• Rising Awareness About Laboratory Tests

Laboratory tests are very essential for the confirmation of the disease as many a times, clinical signs are not enough. Additionally, the World Organization for Animal Health (OIE) mentioned that potentially contaminated material should be used in the laboratory as per the rules and regulations provided by the organization. All these factors are also contributing in the growth of the market.  

• Increasing Demand for Retail Pharmacies

The rise in the number of drugs used for glanders disease delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

Restraints/Challenges

• Threat of Bioterrorism

Glanders is a chronic and fatal disease. Different other species are susceptible to the disease. It is considered to be a potential bioterrorism agent with a fatality rate of 95%. People have gotten glanders from sick animals but the phenomenon is not so common. People who come in close contact with animals with glanders are more likely to get the disease than those who are not. Thus, this works as a serious threat of bioterrorism to people.

• Unavailability of Appropriate Treatments

To treat conditions which are rare, many a times all treatments are not available, especially in the under-developed countries. The severe patients needs to be treated with the advanced techniques but at times, these are not available in the hospitals and clinics. Thus, it hampers the market growth.

This global glanders treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global glanders treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Glanders Treatment Market

Considering the present scenario, COVID-19 has left a major global public health crisis that has impacted practically every business and has a heavy impact on the global crane-heise syndrome market.

During the pandemic, the load on healthcare facilities and professionals was growing in tandem with the rapid increase in patient numbers. Many hospitals have decided to cancel or postpone other procedures. Post pandemic, the situation improved a bit and doctors and physicians could focus on the other syndromes, including these rare syndromes. Travel restrictions has uplifted and treatments are expanding at a high pace. In terms of genetic counselling, telemedicine is also on the rise and is really helpful, especially for treating these diseases.

Global Glanders Treatment Market Scope

The global glanders treatment market is segmented on the basis of treatment, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Tetracyclines
• Ciprofloxacin
• Streptomycin
• Novobiocin
• Gentamicin  

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Others

Glanders Treatment Market Regional Analysis/Insights

The global glanders treatment market is analysed and market size insights and trends are provided by treatment, distribution channel as referenced above.

The major countries covered in the global glanders treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market due to the prevalence of disease.

아시아 태평양 지역은 환자 인구가 증가함에 따라 가장 수익성이 높은 기간으로 간주됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 Glanders 치료 시장 점유율 분석

글로벌 글랜더스 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 글랜더스 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 말초선 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• F. 호프만-라 로슈 유한회사(스위스)
• 마일런 NV(미국)
• 파이저 주식회사(미국)
• 노바티스 AG(스위스)
• 아스트라제네카(영국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• Sun Pharmaceutical Industries Ltd. (인도)
• 브리스톨-마이어스 스퀴브 회사(미국)
• 릴리(미국)
• 암젠 주식회사(미국)
• 머크 KGaA(독일)
• Beckman Coulter Inc. (미국)
• bioMerieux (프랑스)
• Bio-Rad Laboratories, Inc (미국)
• 퀴델 코퍼레이션(미국)
• Eiken Chemical Co., Ltd.(일본)

SKU-69186